Semaglutide

Description

Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), modified with a C18 fatty acid chain conjugation to enable albumin binding and extend half-life. In research settings, Semaglutide is studied for its interactions with GLP-1 receptors in pancreatic, hypothalamic, hepatic, and peripheral tissue models.

BioRhex supplies Semaglutide as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.